EHMT2 and cardiac hypertrophy: G9a may be a potential target for the treatment of early myocardial hypertrophy in the future.88 Kurozumi et al.89 showed that interleukin (IL)-6/SIL-6R stimulation induces p-STAT3 activation and jumonji domain-containing protein (JMJD)2B recruitment.